Table 1. Clinical and laboratory patient characteristics.
| Characteristics | n = 330 |
|---|---|
| Demographics | |
| Age, years | 65 (57–74) |
| Male sex | 216 (65.5) |
| BMI, kg/m2 | 27 (24.2–29.7) |
| Medical history | |
| Hypertension | 296 (89.7) |
| Hyperlipidemia | 308 (93.3) |
| Diabetes mellitus | 106 (32.1) |
| Active smoking | 140 (42.4) |
| Laboratory data | |
| Hemoglobin, g/dl | 13.1 (12–14.3) |
| White blood cell count, G/l | 8.4 (7–10.4) |
| Platelet count, G/l | 209 (176–251) |
| Serum creatinine, mg/dl | 1 (0.9–1.2) |
| High sensitivity CRP, mg/dl | 0.81 (0.33–1.82) |
| Interleukin-6, pg/mL | 15.74 (9.81–27.7) |
| Asymmetric dimethylarginine, μmol/L | 0.86 (0.6–1.34) |
| Medication pre-intervention | |
| Clopidogrel | 316 (95.8) |
| Prasugrel | 14 (4.2) |
| Aspirin | 330 (100) |
| Statins | 315 (95.5) |
| ACE inhibitors/ARB | 285 (86.4) |
| Beta blockers | 231 (70) |
| Proton pump inhibitors | 178 (53.9) |
| Calcium channel blockers | 96 (29.1) |
Continuous data are shown as median (interquartile range). Dichotomous data are shown as n (%).
BMI, body mass index; CRP, C-reactive protein; ACE inhibitors, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers.